KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in TaxesDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Amortizatization of Intangibles (2016 - 2022)

Historic Amortizatization of Intangibles for Gsk (GSK) over the last 7 years, with Q4 2015 value amounting to $1.1 billion.

  • Gsk's Amortizatization of Intangibles rose 40.24% to $1.1 billion in Q4 2015 from the same period last year, while for Dec 2015 it was $4.3 billion, marking a year-over-year increase of 3351.26%. This contributed to the annual value of $1.2 billion for FY2018, which is 12.16% up from last year.
  • Latest data reveals that Gsk reported Amortizatization of Intangibles of $1.1 billion as of Q4 2015, which was up 40.24% from $1.1 billion recorded in Q4 2014.
  • In the past 5 years, Gsk's Amortizatization of Intangibles registered a high of $1.1 billion during Q4 2015, and its lowest value of $50.3 million during Q4 2011.
  • Moreover, its 5-year median value for Amortizatization of Intangibles was $1.1 billion (2013), whereas its average is $862.3 million.
  • In the last 5 years, Gsk's Amortizatization of Intangibles tumbled by 9402.78% in 2011 and then surged by 173290.26% in 2012.
  • Gsk's Amortizatization of Intangibles (Quarter) stood at $50.3 million in 2011, then soared by 1732.9% to $921.8 million in 2012, then increased by 19.79% to $1.1 billion in 2013, then grew by 1.02% to $1.1 billion in 2014, then grew by 0.4% to $1.1 billion in 2015.
  • Its Amortizatization of Intangibles was $1.1 billion in Q4 2015, compared to $1.1 billion in Q4 2014 and $1.1 billion in Q4 2013.